Journal
/
/
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
JoVE Journal
Cancer Research
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Cancer Research
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic Leukemia
DOI:

09:52 min

December 04, 2018

, , , , , , , , ,

Chapters

  • 00:04Title
  • 00:41Fixation, Cell Lysis, and Chromatin Shearing
  • 03:54Chromatin Immunoprecipitation
  • 08:31Results: qRT-PCR with Precipitated DNA Identified Specific Binding of NFAT2 to the LCK Promotor Region
  • 09:30Conclusion

Summary

Automatic Translation

Chronic lymphocytic leukemia (CLL) is the most common leukemia in the western world. NFAT transcription factors are important regulators of development and activation in numerous cell types. Here, we present a protocol for the use of chromatin immunoprecipitation (ChIP) in human CLL cells to identify novel target genes of NFAT2.

Related Videos

Read Article